XTCYF (Pegasus Mercantile) 3-Year EBITDA Growth Rate: 42.20% (As of Mar. 2026) — 56% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Pegasus Mercantile 3-Year EBITDA Growth Rate?

Pegasus Mercantile XTCYF +18.20% 3-Year EBITDA Growth Rate is 42.20% as of Mar. 2026, which is 56% above its 10-year median of 27.10. The stock has 4 warning signs investors should review. Among 324 Credit Services companies, Pegasus Mercantile ranks better than 81.17% on this metric.

Pegasus Mercantile's EBITDA per Share for the three months ended in Mar. 2026 was $-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was 42.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 39.30% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 16.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Pegasus Mercantile was 79.90% per year. The lowest was -121.40% per year. And the median was 27.10% per year.


Pegasus Mercantile  (OTCPK:XTCYF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Pegasus Mercantile 3-Year EBITDA Growth Rate Related Terms


XTCYF vs V, MA, AXP: 3-Year EBITDA Growth Rate Comparison

For the Credit Services subindustry, Pegasus Mercantile's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pegasus Mercantile 3-Year EBITDA Growth Rate vs Credit Services Industry

For the Credit Services industry and Financial Services sector, Pegasus Mercantile's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Pegasus Mercantile's 3-Year EBITDA Growth Rate falls into.



Pegasus Mercantile 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 42.20% mean?
Pegasus Mercantile (XTCYF) has a 3-Year EBITDA Growth Rate of 42.20% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Pegasus Mercantile and its competitors. This is 56% above median its historical median of 27.10. According to the industry distribution chart, Pegasus Mercantile ranks #61 out of 324 companies in the Credit Services industry, placing it in the top 18.8%.
Is Pegasus Mercantile's 3-Year EBITDA Growth Rate too high?
Pegasus Mercantile's current 3-Year EBITDA Growth Rate of 42.20% is 56% above median its 10-year median of 27.10. The Credit Services industry median 3-Year EBITDA Growth Rate is 9.15. Pegasus Mercantile's value of 42.20% is 361.2% above this industry median. Based on the distribution chart, Pegasus Mercantile ranks #61 out of 324 companies in the Credit Services industry, which is in the top quartile — a strong position relative to peers.
How does Pegasus Mercantile's 3-Year EBITDA Growth Rate compare to V and MA?
According to the Credit Services industry distribution chart, Pegasus Mercantile ranks #61 out of 324 companies for 3-Year EBITDA Growth Rate. This places Pegasus Mercantile in the top 19% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 9.15. Pegasus Mercantile's value of 42.20% is 361.2% above this benchmark. While the company's 10-year median is 27.10 vs. the industry median of 9.15, Pegasus Mercantile has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Credit Services company?
The median 3-Year EBITDA Growth Rate among Credit Services companies is 9.15, based on 324 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pegasus Mercantile's current 3-Year EBITDA Growth Rate of 42.20% is 361.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Pegasus Mercantile and its competitors. For the Credit Services industry, the median 3-Year EBITDA Growth Rate is 9.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pegasus Mercantile's current 3-Year EBITDA Growth Rate is 42.20%, which is 56% above median its own 10-year median of 27.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pegasus Mercantile stock overvalued right now?
Based on GuruFocus' analysis, Pegasus Mercantile (XTCYF) is currently considered Fairly Valued. The stock's GF Value™ is $0.03, compared to a current price of $0.03 — trading 10.2% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 42.20%, which is 56% above median its 10-year median of 27.10 and 361.2% above the Credit Services industry median of 9.15. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Pegasus Mercantile (XTCYF), the current 3-Year EBITDA Growth Rate is 42.20% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pegasus Mercantile Business Description

Other Exchanges U040:GermanyLOAN:Canada
Address 1100 - 1111 Melville Street, Vancouver, BC, CAN, V6E 3V6
Pegasus Mercantile Inc is a merchant bank focused on the medical cannabis (non-THC), CBD, and hemp sectors in both Canada and the United States. The Company is also focused on specific areas such as pain, depression, and mental illness, investing in pioneering techniques like micro-dosing using organic compounds and synthetic molecules.